EXETER, NH,– Vapotherm, Inc., announced today it closed a $30 million equity financing last month. The first tranche of $15 million closed on October 30, 2015, and the second tranche is scheduled to close in September 2016. Arnerich Massena led the financing round, which included one new investor, Perceptive Advisors, along with current investors Gilde Healthcare Partners, Morgenthaler Ventures, QuestMark Partners, Kaiser Permanente, Adage Capital Management, Crestline Investors and Cross Creek Capital.
“We are delighted by our investors’ continued support of Vapotherm. Their support helps us provide High Flow Therapy, our unique respiratory solution to improve clinical and economic outcomes for customers and the patients they serve,” said Joe Army, President and CEO of Vapotherm.
Tony Arnerich, CEO of Arnerich Massena, commented “We are enthusiastic about continuing to support Vapotherm. This new capital will help the company continue the expansion of the U.S. field organization, develop new products and expand in select International markets.”
Vapotherm, Inc. is a privately held developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 700,000 patients have been treated with Vapotherm High Flow Therapy. For more information, visit www.vtherm.com.
Contact: John Landry, VP & CFO
T: (603) 658-0011